Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Solveig Hofvind

Showing results (91-100 of 228) with videos related to

Pageof 23
Sort By:
European Radiology|November 12, 2020
Survival among women diagnosed with screen-detected or interval breast cancer classified as true, minimal signs, or missed through an informed radiological reviewKaitlyn M Tsuruda, Tone Hovda, Sameer Bhargava, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 11, 2019
Pathway times in the mammography programme before and after introduction of the breast cancer care pathwayKaitlyn M Tsuruda, Sameer Bhargava, Lars A Akslen, et al.
European Radiology|March 14, 2023
Artificial intelligence in BreastScreen Norway: a retrospective analysis of a cancer-enriched sample including 1254 breast cancer casesHenrik Wethe Koch, Marthe Larsen, Hauke Bartsch, et al.
Springerplus|February 12, 2013
Physical activity and mammographic density in a cohort of postmenopausal Norwegian women; a cross-sectional studySamera Azeem Qureshi, Merete Ellingjord-Dale, Solveig Hofvind, et al.
Journal of Medical Screening|June 23, 2021
Detection and significance of small and low proliferation breast cancerSolveig Hofvind, Gøril Knutsvik, Åsne S Holen, et al.
Radiology|December 15, 2017
Interval Breast Cancer Rates and Histopathologic Tumor Characteristics after False-Positive Findings at Mammography in a Population-based Screening ProgramSolveig Hofvind, Silje Sagstad, Sofie Sebuødegård, et al.
European Journal of Epidemiology|March 6, 2023
Low-dose aspirin and risk of breast cancer: a Norwegian population-based cohort study of one million womenLukas Løfling, Nathalie C Støer, Sara Nafisi, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 11, 2019
Cost differences between digital tomosynthesis and standard digital mammography in a breast cancer screening programme: results from the To-Be trial in NorwayTron Anders Moger, Jayson O Swanson, Åsne Sørlien Holen, et al.
European Radiology|November 4, 2017
Breast compression parameters and mammographic density in the Norwegian Breast Cancer Screening ProgrammeNataliia Moshina, Marta Roman, Gunvor G Waade, et al.
Journal of Medical Screening|September 9, 2025
An economic scenario analysis of implementing artificial intelligence in BreastScreen Norway-Impact on radiologist person-years, costs and effectsTron Anders Moger, Sahand Barati Nardin, Åsne Sørlien Holen, et al.
Pageof 23

Showing results (91-100 of 228) with videos related to

Sort By:
Pageof 23
European Radiology|November 12, 2020
Survival among women diagnosed with screen-detected or interval breast cancer classified as true, minimal signs, or missed through an informed radiological reviewKaitlyn M Tsuruda, Tone Hovda, Sameer Bhargava, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 11, 2019
Pathway times in the mammography programme before and after introduction of the breast cancer care pathwayKaitlyn M Tsuruda, Sameer Bhargava, Lars A Akslen, et al.
European Radiology|March 14, 2023
Artificial intelligence in BreastScreen Norway: a retrospective analysis of a cancer-enriched sample including 1254 breast cancer casesHenrik Wethe Koch, Marthe Larsen, Hauke Bartsch, et al.
Springerplus|February 12, 2013
Physical activity and mammographic density in a cohort of postmenopausal Norwegian women; a cross-sectional studySamera Azeem Qureshi, Merete Ellingjord-Dale, Solveig Hofvind, et al.
Journal of Medical Screening|June 23, 2021
Detection and significance of small and low proliferation breast cancerSolveig Hofvind, Gøril Knutsvik, Åsne S Holen, et al.
Radiology|December 15, 2017
Interval Breast Cancer Rates and Histopathologic Tumor Characteristics after False-Positive Findings at Mammography in a Population-based Screening ProgramSolveig Hofvind, Silje Sagstad, Sofie Sebuødegård, et al.
European Journal of Epidemiology|March 6, 2023
Low-dose aspirin and risk of breast cancer: a Norwegian population-based cohort study of one million womenLukas Løfling, Nathalie C Støer, Sara Nafisi, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 11, 2019
Cost differences between digital tomosynthesis and standard digital mammography in a breast cancer screening programme: results from the To-Be trial in NorwayTron Anders Moger, Jayson O Swanson, Åsne Sørlien Holen, et al.
European Radiology|November 4, 2017
Breast compression parameters and mammographic density in the Norwegian Breast Cancer Screening ProgrammeNataliia Moshina, Marta Roman, Gunvor G Waade, et al.
Journal of Medical Screening|September 9, 2025
An economic scenario analysis of implementing artificial intelligence in BreastScreen Norway-Impact on radiologist person-years, costs and effectsTron Anders Moger, Sahand Barati Nardin, Åsne Sørlien Holen, et al.
Pageof 23